» Articles » PMID: 35922016

Managing the Impact of COVID-19 in Nursing Homes and Long-Term Care Facilities: An Update

Overview
Publisher Elsevier
Specialty General Medicine
Date 2022 Aug 3
PMID 35922016
Authors
Affiliations
Soon will be listed here.
Abstract

Older adults in nursing homes are at greatest risk of morbidity and mortality from SARS-CoV-2 infection. Nursing home residents constituted one-third to more than half of all deaths during the early waves of the COVID-19 pandemic. Following this, widespread adaptation of infection prevention and control measures and the supply and use of personal protective equipment resulted in a significant decrease in nursing home infections and deaths. For nursing homes, the most important determinant of experiencing a SARS-CoV-2 outbreak in the first instance appears to be community-transmission levels (particularly with variants of concern), although nursing home size and quality, for-profit status, and sociodemographic characteristics are also important. Use of visitation bans, imposed to reduce the impact of COVID-19 on residents, must be delicately balanced against their impact on resident, friend or family, and staff well-being. The successful rollout of primary vaccination has resulted in a sharp decrease in morbidity and mortality from SARS-CoV-2 in nursing homes. However, emerging evidence suggests that vaccine efficacy may wane over time, and the use of a third or additional vaccine "booster" doses in nursing home residents restores protection afforded by primary vaccination. Ongoing monitoring of vaccine efficacy in terms of infection, morbidity, and mortality is crucial in this vulnerable group in informing ongoing SARS-CoV-2 vaccine boosting strategies. Here, we detail the impact of SARS-CoV-2 on nursing home residents and discuss important considerations in the management of nursing home SARS-CoV-2 outbreaks. We additionally examine the use of testing strategies, nonpharmacologic outbreak control measures and vaccination strategies in this cohort. Finally, the impact of SARS-CoV-2 on the sector is reflected on as we emphasize the need for adoption of universal standards of medical care and integration with wider public health infrastructure in nursing homes in order to provide a safe and effective long-term care sector.

Citing Articles

Effectiveness of SARS-CoV-2 testing strategies.

Saif-Ur-Rahman K, Nurdin N, Movsisyan A, Kothari K, Conway T, Tierney M Cochrane Database Syst Rev. 2025; 2:CD016192.

PMID: 39991854 PMC: 11848964. DOI: 10.1002/14651858.CD016192.


Management of a COVID-19 outbreak using a multidisciplinary approach and infection prevention control practices at a community living center in Veterans Administration Hospital, North Texas.

Oboho I, Hanna J, Silva-Rodriguez D, Christie-Smith A, Psenicka A, Khongmongkhon A Antimicrob Steward Healthc Epidemiol. 2025; 5(1):e12.

PMID: 39839361 PMC: 11748011. DOI: 10.1017/ash.2024.491.


How did COVID-19 lockdown impact the health of older adults in nursing homes? A scoping review.

San Martin-Erice I, Escalada-Hernandez P, Garcia-Vivar C, Furtado-Eraso S, San Martin-Rodriguez L, Soto-Ruiz N BMC Geriatr. 2024; 24(1):760.

PMID: 39277726 PMC: 11401423. DOI: 10.1186/s12877-024-05356-9.


A model-based assessment of social isolation practices for COVID-19 outbreak response in residential care facilities.

Zachreson C, Tobin R, Walker C, Conway E, Shearer F, McVernon J BMC Infect Dis. 2024; 24(1):880.

PMID: 39210276 PMC: 11360480. DOI: 10.1186/s12879-024-09788-x.


The palliative care experience in Irish nursing homes during the COVID-19 pandemic: a survey of residents, family, and staff.

Doody O, Lombard J, Delamere T, Rabbitte M BMC Palliat Care. 2024; 23(1):126.

PMID: 38773544 PMC: 11110399. DOI: 10.1186/s12904-024-01458-8.


References
1.
Konetzka R, White E, Pralea A, Grabowski D, Mor V . A systematic review of long-term care facility characteristics associated with COVID-19 outcomes. J Am Geriatr Soc. 2021; 69(10):2766-2777. PMC: 8631348. DOI: 10.1111/jgs.17434. View

2.
Veneti L, Boas H, Kristoffersen A, Stalcrantz J, Bragstad K, Hungnes O . Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022. Euro Surveill. 2022; 27(4). PMC: 8796289. DOI: 10.2807/1560-7917.ES.2022.27.4.2200077. View

3.
Anderson D, Grey T, Kennelly S, ONeill D . Nursing Home Design and COVID-19: Balancing Infection Control, Quality of Life, and Resilience. J Am Med Dir Assoc. 2020; 21(11):1519-1524. PMC: 7603995. DOI: 10.1016/j.jamda.2020.09.005. View

4.
Pannus P, Neven K, De Craeye S, Heyndrickx L, Vande Kerckhove S, Georges D . Poor Antibody Response to BioNTech/Pfizer Coronavirus Disease 2019 Vaccination in Severe Acute Respiratory Syndrome Coronavirus 2-Naive Residents of Nursing Homes. Clin Infect Dis. 2021; 75(1):e695-e704. PMC: 8690239. DOI: 10.1093/cid/ciab998. View

5.
Ter Brugge B, van Atteveld V, Fleuren N, Douma M, van der Ploeg M, Hoeksma J . Advance Care Planning in Dutch Nursing Homes During the First Wave of the COVID-19 Pandemic. J Am Med Dir Assoc. 2021; 23(1):1-6.e1. PMC: 8563349. DOI: 10.1016/j.jamda.2021.10.014. View